人工耳蜗并发症与结局:2016至2024年MAUDE数据库全国趋势分析
本研究基于美国FDA MAUDE数据库,提取2016至2024年与人工耳蜗相关的不良事件,分析患者并发症、设备并发症及临床结局的变化趋势。结果显示,2016至2020年所有领域发生率上升且并发症构成比变化;2020至2024年总体并发症计数趋于平稳或下降,但愈合/皮肤、感染/炎症、设备贴合/位置异常/脱落等特定问题构成比持续增加,住院和危及生命结局的构成比也上升。
要点
- 2016至2020年人工耳蜗并发症报告总体上升,2020至2024年总计数趋于平稳或下降。
- 2020至2024年愈合/皮肤、感染/炎症、设备贴合/位置异常/脱落构成比持续增加。
- 住院和危及生命结局的构成比在2020至2024年期间上升。
核心结论
- 尽管2020年后人工耳蜗总体并发症报告趋于稳定,但若干并发症亚型和不良结局的构成比仍在上升。
研究设计与样本
- 横断面研究,基于美国FDA MAUDE多机构数据库,提取2016至2024年人工耳蜗相关不良事件。
主要发现
- 2016至2024年共报告34,426例患者并发症、33,487例设备并发症和26,377例临床结局。
- 2016至2020年所有领域发生率上升且并发症构成比变化。
- 2020至2024年总体并发症计数趋于平稳或下降,但愈合/皮肤、感染/炎症、设备贴合/位置异常/脱落构成比持续增加。
- 2020至2024年住院和危及生命结局的构成比上升。
临床怎么用
- 临床应关注人工耳蜗术后愈合/皮肤、感染/炎症及设备贴合/位置异常/脱落等并发症的监测与处理。
- 需重视住院和危及生命结局的上升趋势,加强术后随访和不良事件报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: As cochlear implant (CI) use expands, complications have become a growing concern. While prior studies analyzed CI failures, few have comprehensively assessed national complication temporal patterns and clinical outcomes. This study evaluates patient and device complication patterns and outcomes from 2016 to 2024. STUDY DESIGN: Cross-sectional. SETTING: Multi-institution database. METHODS: Adverse events related to CIs from 2016 to 2024 were extracted from the US Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database using CI-specific product codes. Complications and outcomes were categorized into themes. Poisson and quasi-Poisson regressions assessed trends in raw counts, and Cochran-Armitage tests evaluated proportional changes of specific complications and outcomes to total counts before (2016-2020) and after (2020-2024) a major voluntary field corrective action. RESULTS: From 2016 to 2024, 34,426 patient complications, 33,487 device complications, and 26,377 clinical outcomes were reported. Between 2016 and 2020, all domains exhibited rising incidence and shifting complication proportions. From 2020 to 2024, overall complication counts plateaued or declined; however, specific issues such as healing/skin, infection/inflammation, and device fit/malposition/detachment continued to increase in proportion to the total number of complications. Hospitalizations and life-threatening outcomes also rose in proportion during this period. CONCLUSION: Although overall CI complication reporting has stabilized post-2020, several complication subtypes and adverse outcomes continue to rise. These findings highlight evolving safety profiles of CIs and underscore the need for targeted device and surgical refinements as well as robust post-market surveillance to guide safer innovation.
引用
- Habib DRS, Bishay AE, Habib MWS, et al. Cochlear Implant Complications and Outcomes: National Trends of the MAUDE Database From 2016 to 2024. Otolaryngol Head Neck Surg. 2026. PMID: 42171210. doi:10.1002/ohn.70297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。